Alternative Medicine Use Increasing For Patients With Chronic Rhinosinusitis
Posted on: Monday, 5 October 2009, 06:10 CDT
A new study suggests that a growing segment of patients are turning to complementary and alternative medical therapies to help treat the symptoms of chronic rhinosinusitis (CRS).
In a paper presented at the 2009 American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers sought to explore the pattern of complementary and alternative medicine (CAM) use in patients with a prior diagnosis of CRS at a rhinology outpatient clinic in Aberdeen, Scotland.
CRS is defined as a group of disorders characterized by inflammation of the mucosa of the nose and paranasal sinuses of at least 12 weeks duration. The group of CRS disorders annually accounts for as many as 22 million office visits and more than 500,000 emergency department visits in the U.S., according to some estimates.
Questionnaires were provided to 75 patients over a two-month period. The questionnaire consisted of demographic information and whether they had ever used CAM from a list of 49 herbal and non-herbal alternative therapies (such as acupuncture, massage, aloe vera, and cod liver oil). Subjects were also asked why they used CAM, where they learned of CAM, whether they found it efficacious, and whether their general practitioner was aware they were using it.
Sixty-five percent of patients had used CAM. Thirty percent of patients used it for chronic rhinosinusitis. Women were significantly more likely to use CAM than men, according to the statistics. Patients who were employed, married, and had university degrees were also more likely to use CAM. Only 43 percent of CAM users had informed their doctor about the use of the therapy.
Researchers noted that patients were reticent about telling their physician about usage of CAM. Clinicians should enquire as to all the medications being taken by patients, and the dangers of non- compliance with conventional medications should be emphasized to CAM users by their treating physician.
Title: Complementary medicine usage in chronic rhinosinusitis
Presenters: Jon Newton, Muhammad Shakeel, DO-HNS, Louise Santangeli
---
On the Net:
Related Articles
- GlobeImmune Announces Presentation of Results From a Randomized Phase 1b Study of the GI-5005 Tarmogen in Patients With Chronic Hepatitis C Infection
- Flamel Technologies Announces Positive Top Line Results of a Clinical Trial of IFN-Alpha-XL Versus PegIntron(TM) in Patients With Chronic Hepatitis C Virus Infection
- TYZEKA(TM) (Telbivudine) Approved in the U.S. As a New Treatment for Patients With Chronic Hepatitis B
- TYZEKA(TM) (Telbivudine) Approved By U.S. Food and Drug Administration (FDA) As a New Treatment for Patients With Chronic Hepatitis B
- Cephalon Announces Positive Results for FENTORA(TM) (Fentanyl Buccal Tablet) for Breakthrough Pain in Patients With Chronic Low Back Pain
- Nursing and Supporting Patients With Chronic Pain
- Naryx Pharma, Inc. Announces Significant Results From Its Phase II Study of SPRC-AB01 in Patients With Chronic Rhinosinusitis
- ChemGenex Launches Multi-Center Phase 2 Clinical Trial of Ceflatonin in Combination With Gleevec in Patients With Chronic Myelogenous Leukemia
- Benephit Infusion System To Be Studied in Patients With Chronic Kidney Disease Undergoing Cardiovascular Procedures
User Comments (0)

RSS Feeds